just now

Liquidity Finder Ltd is incorporated in England and Wales, company number 10610740, registered address 167-169 Great Portland Street, Fifth Floor, London W1W 5PF, United Kingdom.
Published: just now


Currency dynamics, whether through pegs, currency boards, or exchange-rate targets, rarely captivate the attention of FX markets unless there's a hint of abandonment. While most emerging markets have abandoned such mechanisms, recent years have witnessed notable incidents in developed markets. Surplus nations' central banks, like those of Switzerland and the Czech Republic, have aimed to curb currency appreciation through unconventional monetary policies. Despite these instances, revisiting such approaches seems unlikely unless faced with extreme circumstances.
In a departure from the norm, the Danish krone has become a focal point due to unique developments. The extraordinary success of a pharmaceutical company and the resulting demand for its products have led to significant distortions in the local economy, impacting monetary and fiscal policies. Notably, the market capitalization of this pharmaceutical giant surpasses Denmark's GDP. The Danish government acknowledges the need to segregate the pharmaceutical sector from the broader economy, mirroring Norway's separation of onshore and offshore economies due to the outsized influence of its energy industry.
Without the pharmaceutical industry, Denmark's industrial production would have experienced annualized contraction throughout 2023. Despite robust economic indicators, the Danish krone could be considered a minor safe-haven currency, with potential valuation losses from its currency board with the euro. However, recognizing pharmaceutical sales as a sustainable source of current account amplification may lead to a re-rating of the currency, potentially resulting in a higher real effective exchange rate (REER).
It's important to clarify that the scrutiny is not directed at the currency board itself, nor does it question the continuity of Denmark's FX policy. However, the fixed nominal effective exchange rate limits operational freedom, requiring the Danish National bank and the government to implement robust policies to prevent the economy from overheating.
Drawing inspiration from Switzerland's experience may provide insights for Copenhagen. While less high-profile than Denmark, the Swiss franc is also influenced by its pharmaceutical sector. The industry, though employing only a fraction of the workforce, contributes significantly to Swiss GDP and trade balances. The flexible exchange rate allows Switzerland to navigate external yield and risk environments more effectively, preventing onshore accumulation of savings during adverse conditions.
Both Denmark and Switzerland face challenges from their dependence on the US as the largest non-European export market for pharmaceutical products. The burgeoning pharmaceutical-related surpluses could draw political attention, especially considering global trends toward trade barriers and potential border-adjustment taxes on manufactured goods destined for the US.
While celebrating the pharmaceutical prowess of Denmark and Switzerland, it's crucial to acknowledge the potential monetary side effects and political complications. Governments and monetary authorities in both countries will need to carefully balance their policies to prevent distortions from causing serious damage to their economies in the ever-evolving global landscape.
Insights Inspired by BNY Mellon: Credit to Their Analysis for Shaping Some Aspects of This Text
This content may have been written by a third party. ACY makes no representation or warranty and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied by any third-party. This content is information only, and does not constitute financial, investment or other advice on which you can rely.
ACY Securities is one of Australia's fastest growing multi-asset online trading providers, offering ultra-low-cost trading, rock-solid execution, technologically superior account management and premium market analysis.
Select the categories and companies you wish to follow directly to your person rss feed.
Create Custom RSS FeedSign up and join over 5,000 professional members who receive personalized news alerts, curated professional connections, and more for free!
Brokers can offer LMAX perpetual futures alongside FX and CFDs through a single trading account. LMAX says brokers with existing credentials can go live in under five days.
24X National Exchange has filed a proposed rule change with the SEC to launch 24X Options, a general options market trading from 9:30 a.m. to 4:00 p.m. ET. The filing also covers binary KPI options on quarterly revenue, earnings per share and other metrics for 23 of the most actively traded U.S. companies.
cTrader Mobile 5.11 introduces Signals, a new app where traders can browse signals from leading providers and act on them directly in the platform.
ATFX Group has partnered with South Africa-based payment and digital asset infrastructure provider FiveWest to support institutional fund movements for ATFX Connect and add a cryptocurrency funding option for eligible retail clients. Both firms hold FSCA Over-the-Counter Derivative Provider licences.
UK inflation rose to 3.6% in October, keeping a December Bank of England rate rise likely, while the euro hit a fresh one-year low against the dollar ahead of tonight’s Fed minutes. Daily FX analysis from Equals.
GBPUSD has shifted decisively lower. After reaching 1.3228, the pair reversed and initially consolidated around the moving averages before breaking sharply below the 1.3180 area. It is now trading near 1.3169.
Nvidia shares jumped around 4% after hours after beating earnings and revenue expectations and raising its outlook for 75% year on year revenue growth through January 2028. The positive Nvidia results also lifted AI-related stocks, with CoreWeave up 8% and Nebius 10%.
Deutsche Börse Group has appointed Maximilian Weissenrieder as Head of Cash Market from 1 January 2027, succeeding Eric Leupold, who becomes CEO of Eurex. Weissenrieder has led Group M&A and Venture Investments since October 2024 and will retain those duties until a successor is named by the Group.
DEXA, the AI-powered risk management and analytics platform developed by TFB (Tools for Brokers), has connected with Match-Trader, bringing real-time trader analysis and toxic flow detection to brokers on the platform. DEXA classifies trader behaviour from as early as the third trade, with no change to execution systems.
Poland's financial markets regulator, the Polish Financial Supervision Authority (Komisja Nadzoru Finansowego, KNF), is preparing a new product intervention on contracts for difference (CFDs)